163P Health-related quality of life (HRQoL) with pembrolizumab (pembro) vs chemotherapy (chemo) in platinum-pretreated recurrent or metastatic (R/M) nasopharyngeal cancer (NPC): Phase III KEYNOTE-122 study
| Autor: | Chan, A.T.C., Lee, H.F.V., Hong, R-L., Ahn, M-J., Chong, W.Q., Kim, S-B., Fuang, H.G., Caguioa, P.B., Ngamphaiboon, N., Ho, C., Abdul Aziz, M.A.S., Ng, Q.S., Yen, C.J., Soparattanapaisarn, N., Ngan, R., Kho, S.K., Wang, L., Swaby, R., Saraf, S., Siu, L.L. |
|---|---|
| Zdroj: | In Annals of Oncology December 2021 32 Supplement 7:S1452-S1452 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|